Picture of Mochida Pharmaceutical Co logo

4534 Mochida Pharmaceutical Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Momentum

Relative Strength (%)
1m-5.41%
3m-7.95%
6m-24.24%
1yr-21.83%
Volume Change (%)
10d/3m+7.29%
Price vs... (%)
52w High-15.67%
50d MA-5.29%
200d MA-9.9%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)17.14
PEG Ratio (f)0.96
EPS Growth (f)21.76%
Dividend Yield (f)2.74%
Valuation (ttm)IndustryMarket
Price to Book Value0.81
Price to Tang. Book0.81
Price to Free Cashflown/a
Price to Sales1.01
EV to EBITDA6.86

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.12%
Return on Equity3.57%
Operating Margin5.32%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total Revenue¥m101,799102,995110,179103,261102,885106,000108,000-1.26%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-16.07+33.47+27.22-38.3-25.91+24.73+12.7n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Mochida Pharmaceutical Co EPS forecast chart

Profile Summary

Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.

Directors

Last Annual
March 31st, 2024
Last Interim
March 31st, 2024
Incorporated
April 28th, 1945
Public Since
May 13th, 1963
No. of Employees
1,529
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
35,451,509
Blurred out image of a map
Address
1-7, Yotsuya, SHINJUKU-KU, 160-8515
Web
https://www.mochida.co.jp/
Phone
+81 333587211
Auditors
Ernst & Young ShinNihon LLC

4534 Share Price Performance

Upcoming Events for 4534

Mochida Pharmaceutical Co Ltd Annual Shareholders Meeting

Q1 2025 Mochida Pharmaceutical Co Ltd Earnings Release

Dividend For 4534.T - 40.0000 JPY

Q2 2025 Mochida Pharmaceutical Co Ltd Earnings Release

Similar to 4534

Picture of Astellas Pharma logo

Astellas Pharma

jp flag iconTokyo Stock Exchange

Picture of Astena Holdings Co logo

Astena Holdings Co

jp flag iconTokyo Stock Exchange

Picture of CanBas Co logo

CanBas Co

jp flag iconTokyo Stock Exchange

Picture of CellSeed logo

CellSeed

jp flag iconTokyo Stock Exchange

FAQ